ACI
GILD icon

Advance Capital I’s Gilead Sciences GILD Stock Holding History

Advance Capital I’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,100
Closed -$415K – 140
2015
Q4 		$415K Buy
+4,100
New +$427K 0.39% 76
2014
Q1 		– Sell
-19,120
Closed -$1.44M – 215
2013
Q4 		$1.44M Sell
19,120
-960
-5% -$66.8K 0.69% 13
2013
Q3 		$1.26M Buy
20,080
+250
+1% +$14.9K 0.64% 14
2013
Q2 		$1.02M Buy
+19,830
New +$1.03M 0.5% 40

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advance Capital I's GILD Position: Q1 2016 in Review

Advance Capital I sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 4,100 shares — an estimated $415K sold.

Advance Capital I first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $1.44M in Q4 2013. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Advance Capital I reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Advance Capital I sold 4,100 Gilead Sciences shares in Q1 2016, an estimated $415K.
  • Advance Capital I first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
  • Advance Capital I's Gilead Sciences position peaked at $1.44M in Q4 2013.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Advance Capital I's 13F filing for Q1 2016, filed 9 May 2016.